对脉冲类固醇治疗与结核病相关的急性呼吸衰竭的回顾性研究
Masayoshi Higashiguchi1, Tomoshige Matsumoto1, Koji Nishioka1
1Department of Internal Medicine, Osaka Anti-Tuberculosis Association Osaka Fukujuji Hospital, Uchiagetakatsuka-cho 3-10, Neyagawa City, Osaka, 572-0850, Japan.
概括
脉冲类固醇疗法在结核病患者急性呼吸衰竭的治疗中显示出有前途. 这种治疗改善了70%的患者的呼吸和放射学发现,为管理这种严重疾病提供了潜在的新途径.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 结核病 (TB) 可以导致急性呼吸衰竭 (ARF),这种疾病的死亡率很高,尽管有效的抗结核治疗.
- 研究新的治疗策略对于改善结核病相关ARF的结果至关重要.
研究的目的:
- 评估脉冲类固醇治疗 (PST) 的临床特征和有效性,用于结核病后的急性呼吸衰竭患者.
主要方法:
- 追溯分析了接受PST的10名培养证明结核病患者和ARF患者的医疗记录.
- 对临床数据,胸部CT发现和治疗反应的审查.
主要成果:
- 胸部CT显示在所有患者中分散的地面玻璃不透明度和巩固.
- 70% (7/10) 的患者表现出对PST的积极反应,呼吸状况和放射性发现有显著改善.
- 六名患者在没有补充氧气的情况下出院,而三名患者没有反应并死亡.
结论:
- 脉冲类固醇治疗可以显著改善由于结核病而经历急性呼吸衰竭的选择患者的结果.
- 在治疗结核病引起的严重呼吸道损害方面,PST是一种潜在的有价值的辅助治疗方法.
相关概念视频
Pulmonary Tuberculosis V
219
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
219
Pulmonary Tuberculosis IV
182
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
182
Pulmonary Tuberculosis II
282
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
282
Pulmonary Tuberculosis I
293
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
293
Pulmonary Tuberculosis III
385
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
385
COPD: Management Using Bronchodilators and Corticosteroids
256
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
256


